Colchicine demonstrated a significant reduction in inflammatory markers (CRP, ESR, and WBC) in metabolic syndrome (MetS) patients, with improvements in HOMA-IR, fasting insulin, and glucose effectiveness, suggesting enhanced metabolic function [21]. This evidence concerns the gene INS and metabolic syndrome.